News | 21 October 2026
Evonik launches Lypron to boost ruminant performance and cut feed costs
Lysine is one of the most limiting amino acids in ruminant nutrition and a critical driver of animal performance
Lysine is one of the most limiting amino acids in ruminant nutrition and a critical driver of animal performance
Rewin Health is also working with healthcare institutions, special schools and government bodies to integrate digital therapeutics into mainstream support systems
New milestone in local radioisotope production aims to support PET imaging
Nearly 1,800 adults enrolled across 109 sites in North America and Europe
Carboplatin Injection is indicated for the treatment of advanced ovarian carcinoma
These awards for Tanuku and Patalganga teams recognize their dedication to a safe, compliant and rewarding workplace
New grades feature greater rigidity and excellent polishability, suitable for fixed and removable prosthetic restorations
Sanofi will now work with provincial, territorial and federal drug programs to support access to the treatment for eligible patients through public drug plans
Exports & formulations power growth
The approvals cover Vancomycin and Fluorouracil in Kazakhstan, Fulvestrant in Peru, Methotrexate in Kuwait, and Meropenem in Argentina
Sharpens focus on healthcare innovation and growth in India
Both funds will target companies spanning biopharmaceuticals, medical devices, diagnostics and technology-enabled healthcare services
Industry leaders will discuss AI adoption, cybersecurity, ERP modernisation and regulatory compliance as technology takes centre stage in pharma’s next phase of growth
Lonza has completed its shift to a pure-play CDMO following its exit from the Capsules & Health Ingredients business and further divestments
Pfizer will take responsibility for clinical development, manufacturing, regulatory affairs and commercialisation after the collaboration term
The study will evaluate whether AI-assisted endoscopy can help clinicians detect upper gastrointestinal malignancies earlier and more effectively
The funding will support the advancement of Soufflé’s three lead programs into clinical studies
The partnership aims to accelerate the development of innovative treatments by using artificial intelligence to engineer proteins
India-specific pricing to improve affordability & accessibility for children with growth disorders
Subscribe To Our Newsletter & Stay Updated
